1
TITLE: HELIOS-A: 9-month results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy  Full Text
AUTHORS: Adams, D; Tournev, I; Taylor, M; Coelho, T; Plante Bordeneuve, V; Berk, J; Gonzalez Duarte, A; Gillmore, J; Low, SC; Sekijima, Y; Obici, L; Blakesley, R; Arum, S; Shilling, R; Vest, J; Polydefkis, M;
PUBLISHED: 2021, SOURCE: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, VOLUME: 26, ISSUE: 3
INDEXED IN: WOS